v3.26.1
Stockholders' Equity (Deficit)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Stockholders' Equity (Deficit)

8. Stockholders’ Equity (Deficit)

2024 Stock Repurchase Program

On February 6, 2024, the Board of Directors authorized the repurchase of up to $50.0 million of shares of the Company’s common stock through March 1, 2026. The program expired on March 1, 2026, and no shares were repurchased during the six months ended June 30, 2026. Over the life of the program, the Company repurchased 15,448,533 shares for an aggregate of $40.5 million.

Common Shares Reserved

As of June 30, 2026, the Company had reserved shares of common stock for future issuance under equity compensation plans as follows (in thousands):

 

 

 

Securities To Be Issued Upon Exercise Of Options

 

 

Securities To Be Issued Upon Release Of Restricted Stock

 

 

Number Of Remaining Securities Available For Future Issuance

 

2022 Inducement Equity Incentive Plan

 

 

6,795

 

 

 

126

 

 

 

1,090

 

2011 Equity Incentive Plan

 

 

15,904

 

 

 

18,984

 

 

 

22,722

 

2017 Inducement Award Plan

 

 

 

 

 

 

 

 

61

 

2017 Employee Stock Purchase Plan

 

 

 

 

 

 

 

 

1,543

 

SomaLogic Plans

 

 

10,450

 

 

 

26

 

 

 

 

Total common stock reserved for future issuance

 

 

33,149

 

 

 

19,136

 

 

 

25,416